West China Hospital: Carcinoma trials
The registry lists 18 Carcinoma studies with West China Hospital as lead sponsor. 10 are open to participants now and 0 have results posted.
Phase 1 3Phase 2 12Phase 3 2No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Multicenter, Single-Arm, Prospective Phase II Study of Neoadjuvant Cryo-Thermal Ablation Combined With Toripalimab and Chemotherapy for Resectable Stage IB-IIIB Non-Small Cell Lung CancerRecruitingNCT07855965Phase 2
- Textbook Outcomes of Right Hemihepatectomy in Patients With Hepatocellular CarcinomaRecruitingNCT06950827
- Prognostic Impact of Adjuvant Therapy in Primary Hepatic Sarcomatoid CarcinomaRecruitingNCT06950814
- Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical CarcinomaRecruitingNCT06831175Phase 2
- PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCCRecruitingNCT06742424Phase 2
- Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTTRecruitingNCT06664996Phase 2
- Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell CarcinomasRecruitingNCT06225921Phase 1
- Synchronous or Sequential Radiotherapy for Advanced Esophageal Squamous Cell Carcinoma With Oligometastases.Not yet recruitingNCT06143722Phase 2
- Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaNot yet recruitingNCT04414566Phase 3
- Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical CarcinomaRecruitingNCT04318730Phase 2
- Streptococcus Salivarius K12 for Prevention and Treatment of Oral Mucositis in Patients Undergoing RadiotherapyCompletedNCT05918224Phase 2
- Application of mRNA Immunotherapy Technology in Hepatitis B Virus-related Refractory Hepatocellular CarcinomaStatus unknownNCT05738447Phase 1
- Safety and Efficacy of Mitomycin C-based HIPEC After srHCC and PM of HCCStatus unknownNCT05544253Phase 2/3
- Neoadjuvant Chemotherapy, Tislelizumab With Afatinib for HNSCCCompletedNCT05516589Phase 2
- BH4 in the Prevention and Treatment of Radiation-induced Skin Reactions for Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)Status unknownNCT05299203Phase 1
- Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell CarcinomaActive, not recruitingNCT04387500Phase 2
- Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell CarcinomaStatus unknownNCT04385654Phase 2
- Sintilimab in FH-deficient Renal Cell CarcinomaStatus unknownNCT04146831Phase 2